BUCKINGHAM STRATEGIC WEALTH, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
BUCKINGHAM STRATEGIC WEALTH, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$844,595
+22.4%
31,0000.0%0.01%
+20.0%
Q2 2023$689,750
+9.2%
31,000
-0.3%
0.01%
-9.1%
Q1 2023$631,7430.0%31,1050.0%0.01%0.0%
Q4 2022$631,743
-8.7%
31,105
+15.2%
0.01%
-21.4%
Q3 2022$692,000
+7.8%
27,0000.0%0.01%
+7.7%
Q2 2022$642,000
+5.6%
27,0000.0%0.01%
+8.3%
Q1 2022$608,000
+13.6%
27,0000.0%0.01%
+20.0%
Q4 2021$535,000
+0.8%
27,0000.0%0.01%
-9.1%
Q3 2021$531,000
-10.6%
27,0000.0%0.01%
-21.4%
Q2 2021$594,000
-7.5%
27,0000.0%0.01%
-56.2%
Q1 2021$642,000
-9.1%
27,0000.0%0.03%
-13.5%
Q4 2020$706,000
+50.2%
27,0000.0%0.04%
+2.8%
Q3 2020$470,000
+79.4%
27,000
+22.7%
0.04%
+44.0%
Q1 2020$262,000
-1.5%
22,0000.0%0.02%
-3.8%
Q4 2019$266,000
-14.5%
22,0000.0%0.03%
-23.5%
Q3 2019$311,000
+26.9%
22,0000.0%0.03%
+25.9%
Q2 2019$245,000
-5.0%
22,0000.0%0.03%
-18.2%
Q1 2019$258,000
-12.2%
22,0000.0%0.03%
-26.7%
Q4 2018$294,000
+5.0%
22,000
+10.0%
0.04%
+4.7%
Q3 2018$280,000
-10.8%
20,0000.0%0.04%
-15.7%
Q2 2018$314,000
-13.0%
20,0000.0%0.05%
-32.0%
Q4 2017$361,000
-6.5%
20,0000.0%0.08%
-18.5%
Q3 2017$386,000
+63.6%
20,0000.0%0.09%
+67.3%
Q2 2017$236,000
+7.8%
20,0000.0%0.06%
-14.1%
Q1 2017$219,000
+51.0%
20,0000.0%0.06%
+36.2%
Q4 2016$145,000
+11.5%
20,0000.0%0.05%
+6.8%
Q3 2016$130,000
+19.3%
20,0000.0%0.04%
+18.9%
Q2 2016$109,000
+16.0%
20,0000.0%0.04%
+19.4%
Q1 2016$94,000
-6.0%
20,0000.0%0.03%
-8.8%
Q4 2015$100,000
+33.3%
20,0000.0%0.03%
+30.8%
Q3 2015$75,000
-37.5%
20,0000.0%0.03%
-33.3%
Q2 2015$120,000
+7.1%
20,0000.0%0.04%
-7.1%
Q1 2015$112,000
+86.7%
20,0000.0%0.04%
+82.6%
Q4 2014$60,000
+11.1%
20,0000.0%0.02%
+4.5%
Q3 2014$54,000
-3.6%
20,0000.0%0.02%
-8.3%
Q2 2014$56,000
-35.6%
20,0000.0%0.02%
-40.0%
Q1 2014$87,000
+35.9%
20,0000.0%0.04%
+33.3%
Q4 2013$64,000
+100.0%
20,0000.0%0.03%
+76.5%
Q3 2013$32,000
-8.6%
20,0000.0%0.02%
-15.0%
Q2 2013$35,00020,0000.02%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders